206 related articles for article (PubMed ID: 35511056)
1. Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey.
Tribouilloy C; Bohbot Y; Kubala M; Ruschitzka F; Popescu B; Wendler O; Laroche C; Bartha E; Ince H; Simkova I; Vahanian A; Iung B
Eur Heart J; 2022 Aug; 43(29):2756-2766. PubMed ID: 35511056
[TBL] [Abstract][Full Text] [Related]
2. Tricuspid regurgitation: Frequency, clinical presentation, management and outcome among patients with severe left-sided valvular heart disease in Europe. Insights from the ESC-EORP Valvular Heart Disease II survey.
Dreyfus J; Komar M; Attias D; De Bonis M; Ruschitzka F; Popescu BA; Laroche C; Tribouilloy C; Bogachev Prokophiev A; Mizariene V; Bax JJ; Maggioni AP; Messika-Zeitoun D; Vahanian A; Iung B;
Eur J Heart Fail; 2024 Apr; 26(4):994-1003. PubMed ID: 38374610
[TBL] [Abstract][Full Text] [Related]
3. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
[TBL] [Abstract][Full Text] [Related]
4. Meta-Analysis Global Group in Chronic Heart Failure score for the prediction of mortality in valvular heart disease.
Lv J; Xu H; Ye Y; Li Z; Wang W; Zhang B; Zhao Q; Zhang H; Zhao Z; Liu Q; Wang B; Duan Z; Yu Z; Guo S; Zhao Y; Gao R; Ge J; Wu Y;
ESC Heart Fail; 2024 Feb; 11(1):349-365. PubMed ID: 38012105
[TBL] [Abstract][Full Text] [Related]
5. Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry.
Bohbot Y; Habib G; Laroche C; Stöhr E; Chirouze C; Hernandez-Meneses M; Melissopoulou M; Mutlu B; Scheggi V; Branco L; Olmos C; Reyes G; Pazdernik M; Iung B; Sow R; Mirocevic M; Lancellotti P; Tribouilloy C;
Eur J Heart Fail; 2022 Jul; 24(7):1253-1265. PubMed ID: 35508915
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and Prognosis of Patients With Nonvalvular Atrial Fibrillation and Significant Valvular Heart Disease Referred for Electrical Cardioversion.
Vo NM; Leung M; van Rosendael PJ; Goedemans L; van Wijngaarden SE; Prihadi EA; van der Bijl P; Ajmone Marsan N; Delgado V; Bax JJ
Am J Cardiol; 2020 Aug; 128():84-91. PubMed ID: 32650929
[TBL] [Abstract][Full Text] [Related]
7. Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation - The Fushimi AF Registry.
Doi K; Ogawa H; Ishigami K; Ikeda S; Aono Y; Hamatani Y; Fujino A; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M;
Circ J; 2020 Apr; 84(5):714-722. PubMed ID: 32213725
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation.
Samaras A; Vrana E; Kartas A; Moysidis DV; Papazoglou AS; Doundoulakis I; Fotos G; Rampidis G; Tsalikakis DG; Efthimiadis G; Karvounis H; Tzikas A; Giannakoulas G
BMC Cardiovasc Disord; 2021 Sep; 21(1):453. PubMed ID: 34536990
[TBL] [Abstract][Full Text] [Related]
9. Distribution, Characteristics, and Management of Older Patients With Valvular Heart Disease in China: China-DVD Study.
Xu H; Liu Q; Cao K; Ye Y; Zhang B; Li Z; Hao J; Qi X; Zhao Q; Liu S; Gao R; Wu Y;
JACC Asia; 2022 Jun; 2(3):354-365. PubMed ID: 36338396
[TBL] [Abstract][Full Text] [Related]
10. Relationship between valvular structure and biochemical indices of non-valvular atrial fibrillation and senile degenerative valvular heart disease.
Chen JQ; Zeng X; Li KC; Huang JL; Guo BL; Zhou X
J Thorac Dis; 2023 Feb; 15(2):611-619. PubMed ID: 36910075
[TBL] [Abstract][Full Text] [Related]
11. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.
Iung B; Baron G; Butchart EG; Delahaye F; Gohlke-Bärwolf C; Levang OW; Tornos P; Vanoverschelde JL; Vermeer F; Boersma E; Ravaud P; Vahanian A
Eur Heart J; 2003 Jul; 24(13):1231-43. PubMed ID: 12831818
[TBL] [Abstract][Full Text] [Related]
12. Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.
De Caterina R; Renda G; Carnicelli AP; Nordio F; Trevisan M; Mercuri MF; Ruff CT; Antman EM; Braunwald E; Giugliano RP
J Am Coll Cardiol; 2017 Mar; 69(11):1372-1382. PubMed ID: 28302288
[TBL] [Abstract][Full Text] [Related]
13. Left-sided valvular heart disease in dialysis recipients: a single-centre observational study.
Elewa M; Mitra S; Jayanti A
Clin Kidney J; 2023 Jul; 16(7):1092-1101. PubMed ID: 37398684
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease.
Zhang B; Xu H; Zhang H; Liu Q; Ye Y; Hao J; Zhao Q; Qi X; Liu S; Zhang E; Xu Y; Gao R; Pibarot P; Clavel MA; Wu Y;
J Am Coll Cardiol; 2020 Apr; 75(14):1659-1672. PubMed ID: 32273031
[TBL] [Abstract][Full Text] [Related]
15. Profiles of hospitalized patients with valvular heart disease: Experience of a tertiary center.
Esteves AF; Brito D; Rigueira J; Ricardo I; Pires R; Pedro MM; Veiga F; Pinto F
Rev Port Cardiol (Engl Ed); 2018 Dec; 37(12):991-998. PubMed ID: 30554887
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).
Thomas KL; Jackson LR; Shrader P; Ansell J; Fonarow GC; Gersh B; Kowey PR; Mahaffey KW; Singer DE; Thomas L; Piccini JP; Peterson ED
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29273635
[TBL] [Abstract][Full Text] [Related]
17. Stages of Valvular Heart Disease Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
Shelbaya K; Claggett B; Dorbala P; Skali H; Solomon SD; Matsushita K; Konety S; Mosley TH; Shah AM
Circulation; 2023 Feb; 147(8):638-649. PubMed ID: 36524478
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy).
Ezekowitz MD; Nagarakanti R; Noack H; Brueckmann M; Litherland C; Jacobs M; Clemens A; Reilly PA; Connolly SJ; Yusuf S; Wallentin L
Circulation; 2016 Aug; 134(8):589-98. PubMed ID: 27496855
[TBL] [Abstract][Full Text] [Related]
19. Assessment of cardio-renal-hepatic function in patients with valvular heart disease: a multi-biomarker approach-the cardio-renal-hepatic score.
Lv J; Zhang B; Ye Y; Li Z; Wang W; Zhao Q; Liu Q; Zhao Z; Zhang H; Wang B; Yu Z; Duan Z; Guo S; Zhao Y; Gao R; Xu H; Wu Y;
BMC Med; 2023 Jul; 21(1):257. PubMed ID: 37455313
[TBL] [Abstract][Full Text] [Related]
20. Clinical and echocardiographic follow-up in pregnant patients with valvular heart disease.
Gümrükçüoğlu HA; Güler A; Odabaşı D; Şimşek H; Şahin M; Akdağ S; Karapınar H; Akyol A; Güneş Y; Tuncer M
Turk Kardiyol Dern Ars; 2013 Jan; 41(1):31-7. PubMed ID: 23518936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
